Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

In 1989 a patient with myalgic encephalomyelitis (ME) came to see Dr Raymond Perrin in his capacity as an osteopath. The man ...

If you feel a cold coming on, consider treatments and behaviors to help you manage symptoms.1. Get Enough SleepA lack of ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

Australia’s toll roads were introduced in the 1980s as part of a shift towards public-private partnerships (PPPs). Private ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

The Conifer Park warns that overuse of nasal sprays can cause long-term effects such as chronic congestion, inability to identify triggers, worsening congestion, and withdrawal symptoms such as, ...

The once and future president months ago said that he would kill the vehicle tolling program, but if Gov. Kathy Hochul acts ...